Health care law definition of ‘affordable’ vague
Researchers at IU and Cornell say that how the federal government defines "affordable" could leave millions of dependents of low and moderate income workers without reasonably priced insurance.
Researchers at IU and Cornell say that how the federal government defines "affordable" could leave millions of dependents of low and moderate income workers without reasonably priced insurance.
Hill-Rom Holdings Inc., a medical-equipment company based in Indiana, agreed Tuesday to pay nearly $42 million to settle a government lawsuit. The government had accused the company of knowingly submitting false claims to Medicare from 1999 to 2007.
Indianapolis’ largest independent physician group, American Health Network, doesn’t want to sell to a hospital, but its CEO hopes it can hold on until accountable care kicks in.
Dr. Ed Kowlowitz, owner and medical director of the Center for Pain Management in Indianapolis, recently challenged a regional Medicare reimbursement policy and, surprisingly, won. He spoke with IBJ about the experience, as well how his three-physician practice is growing even while many physician practices are selling to hospitals.
Even though Google Inc. has given up on the business of electronic personal health records, Fort Wayne-based NoMoreClipboard.com is launching a new service it thinks will crack open the market.
If approved for continuation maintenance, Eli Lilly and Co.’s Alimta could be used for longer stretches in lung cancer patients, generating more revenue.
Former policyholders of WellPoint Inc., who won a right to a class-action trial over their claims that they were shortchanged when the company went public a decade ago, will have to put their trial plans on hold.
John Thompson’s humble approach to community service has earned him the distinction of being the 18th recipient of IBJ’s Michael A. Carroll Award, given annually to a man or woman who has demonstrated the former deputy mayor’s qualities of determination, humility and devotion to the community.
The deal helps WellPoint compete for employers with the U.S. state-run marketplaces set to open in 2014 under President Obama’s health-care overhaul.
Zotec Partners, a fast-growing physician-billing management company based in Carmel, has acquired a family-owned medical-billing firm with 100 employees based in Florida.
A German researcher disputed the validity of a study that found Byetta and another diabetes drug increase cancer risk.
Dr. Murray Korc, an internationally known pancreatic cancer researcher, comes to the cancer center as the first Myles Brand Professor of Cancer Research. The position is funded through a Lilly Endowment grant.
Benefit consultant Nyhart says the typical Hoosier is paying $105 per month for single coverage and $417 per month for family coverage.
The top event for regulatory professionals in the health care industry is headed to Indianapolis next month. The annual conference of the Regulatory Affairs Professionals Society, or RAPS, is expected to draw thousands of members representing 120 companies and organizations.
Drugmaker Eli Lilly and Co. said Tuesday it will spend $30 million over five years to fight chronic illnesses like heart disease, diabetes, cancer and respiratory disease in developing countries.
Drugmakers Eli Lilly and Co. and Amylin Pharmaceuticals Inc. said Monday that patients taking their potential once-weekly diabetes treatment, Bydureon, saw a significant improvement in cardiovascular risk factors.
IBM’s supercomputer system, best known for trouncing the world’s best “Jeopardy!” players on TV, is being tapped by one of the nation’s largest health insurers to help diagnose medical problems and authorize treatments.
Residents of the Anderson area—when they paid with health insurance provided by an employer—spent 76 percent more on health care in 2009 than the average American with employer health insurance, highest among all metropolitan areas in the nation.
The hype over accountable care organizations—something every major hospital in Indianapolis is moving to become—is increasingly being laced with skepticism as the economics behind the idea get more scrutiny.